Bain Capital Public Equity Management’s Spyre Therapeutics SYRE Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Shares Change %	Capital Flow	Portfolio Weight	Portfolio Position
2018 Q2	–	Sell	-384	Closed	-$95K	–	77
2018 Q1	$95K	Buy	+384	New	+$95K	0.01%	55